France borrows at 4.10% over 10 years, highest since 2008
Prefer us on GoogleThe French government's ten-year borrowing rate reached 4.10% this week, its highest level since November 2008. This increase raises concerns in the bond markets, particularly due to the upcoming review of France's sovereign rating by Fitch, scheduled for August 28. Investors fear rising budgetary tensions and the impact on French debt. The OAT-Bund spread fluctuates between 74 and 79 basis points, indicating a lack of confidence in France. The debt burden is expected to increase by €12.3 billion by 2027, complicating deficit management. A downgrade by Fitch could prompt some funds to reduce their exposure to French debt. The 4.10% rate also affects mortgage loans and financing for local authorities. Long-term rates are also rising in the United States, Japan, and the United Kingdom, but France faces specific budgetary vulnerabilities.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.
You may also like
Trump Names Hyperliquid Entering the U.S., A Moment of 'Reconciliation' for DeFi
Nasdaq to Offer 23-Hour Trading for U.S. Stocks, Intensifying Competition with Tokenized Stocks
BitGo Registered as a Cryptocurrency Business in South Korea, Reports Say
Interpretation of Selling Pressure from the Transfer of 308,884 HYPE
800 Billion Won Investment: The Challenge of 'App Integration' for Hanwha Investment & Securities and Coinone
Bitcoin Breaks Above $70,000, Lifting Crypto Financial Stocks | WEEX TradFi Daily (August 20, 2026)
Expanded U.S. Treasury long-bond buybacks helped pull yields lower and supported a modest rebound in risk appetite, with the major indexes closing slightly higher. At the same time, Bitcoin briefly rose above $70,000 and lifted crypto-linked equities, while positive Phase 3 vaccine data from Merck and Moderna pushed healthcare and biotech stocks higher. SK Hynix’s large-scale buyback also kept attention on the storage cycle and AI-related demand. Markets are continuing to digest the relatively hawkish Fed minutes while positioning ahead of earnings from Alibaba and Walmart.
Budget 2027: Bercy Tightens the Belt on All Ministries Except Defense
CLARITY Act rush could derail deal, Gallego says
$190 Billion in 24 Hours: What's Really Driving Bitcoin and Ethereum's Biggest Rally of the Summer
Bitcoin and Ethereum surged in a historic 24-hour rally that added $190 billion to the crypto market and triggered $2.98 billion in liquidations. Here's what Treasury buybacks, a massive short squeeze, and new SEC rules mean for traders on WEEX.
Wall Street Morning Briefing: Besant Presses Long Bond 'Stop Loss' Button, Gold and Bitcoin Surge; Moderna Ignites Pharma Bull Market, AI Momentum Stocks Liquidated
Full Speech by Wang Xingxing at the 2026 World Robot Conference: Embodied Intelligence of ChatGPT Will Arrive in Two to Three Years at the Fastest
Arthur Hayes: Waiting for Fed Signals to Reload for the Crypto Bull Market
AI agents could make today's billion-dollar crypto hacks look like 'pennies,' industry leaders warn
Surge in AI Debt Financing in the U.S. May Draw Market Attention in September
White House Meeting Overview: What Did Trump Say?
Is Venture Capital Dead? A "Letter of Advice" to All Soon-to-be Obsolete Fund Managers
China Expands Digital Yuan Operating Network to 30 Institutions, Adding 8 Local Banks
Tipping in the United States: Customs and Suggested Amounts to Avoid Overspending
Trillion-Dollar Consumer Loan Market: Key Players Missing
Exports: The First Effects of Agreements with the US and the EU Emerge, with Beef as the Star Product
Interpretation of SEC's New Crypto Regulations: No Registration Required for Fundraising Below $5 Million, Is the Altcoin Season Coming Back?
Middle East Situation Update: Iran to Announce New Strait Route, US Claims 65 Merchant Ships Redirected
Record Delinquency Among Families: What to Do When Debts Accumulate and When to Consider Refinancing a Loan
Wall Street Begins to Look Beyond Bitcoin's Decline
Bitcoin is a 'secret code' for retiring without selling, according to analyst
AILA Raises $3 Million to Expand AI-Powered Learning Solutions
Why Moderna (MRNA) Stock More Than Doubled: The INTerpath-001 Cancer Vaccine Result, Explained
Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.
Web3: Foreign Media Reports that the Altcoin Market in 2026 May Depend on ISM Recovery
CoinFerenceX and the best event join forces to launch “CoinFerenceX The Best Event Singapore,” the decentralized summit
BCCC Introduces JPYC for Annual Membership Fee Payments
Trump Names Hyperliquid Entering the U.S., A Moment of 'Reconciliation' for DeFi
Nasdaq to Offer 23-Hour Trading for U.S. Stocks, Intensifying Competition with Tokenized Stocks
BitGo Registered as a Cryptocurrency Business in South Korea, Reports Say
Interpretation of Selling Pressure from the Transfer of 308,884 HYPE
800 Billion Won Investment: The Challenge of 'App Integration' for Hanwha Investment & Securities and Coinone
Bitcoin Breaks Above $70,000, Lifting Crypto Financial Stocks | WEEX TradFi Daily (August 20, 2026)
Expanded U.S. Treasury long-bond buybacks helped pull yields lower and supported a modest rebound in risk appetite, with the major indexes closing slightly higher. At the same time, Bitcoin briefly rose above $70,000 and lifted crypto-linked equities, while positive Phase 3 vaccine data from Merck and Moderna pushed healthcare and biotech stocks higher. SK Hynix’s large-scale buyback also kept attention on the storage cycle and AI-related demand. Markets are continuing to digest the relatively hawkish Fed minutes while positioning ahead of earnings from Alibaba and Walmart.
Latest articles
Latest coin listings on WEEX
